טוען...
An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis
The objective of this study was to determine the pharmacokinetic profile of meropenem in automated peritoneal dialysis (APD) patients. In 6 patients without peritonitis, a single dose of 0.5 g of meropenem was applied intraperitoneally (i.p.) or intravenously (i.v.) and concentrations in serum and d...
שמור ב:
הוצא לאור ב: | Antimicrob Agents Chemother |
---|---|
Main Authors: | , , , , , , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
American Society for Microbiology
2016
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4862547/ https://ncbi.nlm.nih.gov/pubmed/26902765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02664-15 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|